Literature DB >> 10508137

Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigen.

D W Chan1, C A Kelley, T L Ratliff, D D'Agostino, J Ritchey, D J Lamb, J Beck, N Lott, M H Wener, P Daum, R E Henkin, D N Kaske, D W Golightly, J McBride, G Layco, M K Ota, M J Tanasijevic, C Grudzien, D L Woodrum, K R Bray, P C Southwick, G H Gasior, K G Loveland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508137

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  1 in total

1.  A pilot study on percent free prostate specific antigen as an additional tool in prostate cancer screening.

Authors:  Julia Omar; Zarina Jaafar; Mohamed Rusli Abdullah
Journal:  Malays J Med Sci       Date:  2009-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.